These novel treatments, Tirzepatide , represent a significant advancement in treating obesity and possibly related ailments . They all are classified as GLP-1 hormone activators , signifying they function to replicate the endogenous GLP-1 peptide, stimulating insulin secretion and suppressing food intake. While Retatrutide each one functions lar… Read More